author-photo

Thomas R. Kreil

Baxter International

117

Papers

1904

Citations

Citation Trend

Filter By

Papers (85) Sort By

Journal Conference Others

Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults

2021
Show All
- Source
- Cite
- Save
Citations (3)
Longitudinal analysis of SARS-CoV-2 antibodies in 8000 U.S. first-time convalescent plasma donations.

2021 Transfusion
Show All
- Source
- Cite
- Save
Citations (5)
Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins.

2021 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
The kinetic of SARS-CoV-2 antibody (Ab) decline determines the threshold for Ab persistence up to one year

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (4)
No SARS-CoV-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Viral contamination in biologic manufacture and implications for emerging therapies

2020 Nature Biotechnology
Show All
- Source
- Cite
- Save
Citations (31)
SARS-CoV-2 and the safety margins of cell-based biological medicinal products.

2020 Biologicals
Show All
- Source
- Cite
- Save
Citations (4)
Synthesis of ‘Nereid’, a new phenol-free detergent to replace Triton X-100 in virus inactivation

2020
Show All
- Source
- Cite
- Save
Citations (0)
Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations.

2020 Transfusion
Show All
- Source
- Cite
- Save
Citations (19)